These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30789856)

  • 1. Ilaprazole Compared With Rabeprazole in the Treatment of Duodenal Ulcer: A Randomized, Double-blind, Active-controlled, Multicenter Study.
    Fan L; Xianghong Q; Ling W; Ying H; Jielai X; Haitang H
    J Clin Gastroenterol; 2019 Oct; 53(9):641-647. PubMed ID: 30789856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, parallel, double-blind comparison of the ulcer-healing effects of ilaprazole and omeprazole in the treatment of gastric and duodenal ulcers.
    Ho KY; Kuan A; Zaño F; Goh KL; Mahachai V; Kim DY; Yoon HM
    J Gastroenterol; 2009; 44(7):697-707. PubMed ID: 19434360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ilaprazole for the treatment of duodenal ulcer: a randomized, double-blind and controlled phase III trial.
    Wang L; Zhou L; Hu H; Lin S; Xia J
    Curr Med Res Opin; 2012 Jan; 28(1):101-9. PubMed ID: 22070512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ilaprazole on the healing of endoscopic submucosal dissection-induced gastric ulcer: randomized-controlled, multicenter study.
    Bang CS; Shin WG; Seo SI; Choi MH; Jang HJ; Park SW; Kae SH; Yang YJ; Shin SP; Baik GH; Kim HY
    Surg Endosc; 2019 May; 33(5):1376-1385. PubMed ID: 30167954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new PPI, ilaprazole compared with omeprazole in the treatment of duodenal ulcer: a randomized double-blind multicenter trial.
    Wang L; Zhou L; Lin S; Hu H; Xia J
    J Clin Gastroenterol; 2011 Apr; 45(4):322-9. PubMed ID: 20679904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rabeprazole is superior to ranitidine in the management of active duodenal ulcer disease: results of a double-blind, randomized North American study.
    Breiter JR; Riff D; Humphries TJ
    Am J Gastroenterol; 2000 Apr; 95(4):936-42. PubMed ID: 10763941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ilaprazole: Is this a superior proton pump inhibitor for duodenal ulcer?
    Bohidar NP; Krishna K; Panda BK; Patel C
    Trop Gastroenterol; 2013; 34(2):95-8. PubMed ID: 24377157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer: a European multicentre study.
    Dekkers CP; Beker JA; Thjodleifsson B; Gabryelewicz A; Bell NE; Humphries TJ
    Aliment Pharmacol Ther; 1999 Feb; 13(2):179-86. PubMed ID: 10102948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study.
    Kinoshita Y; Kato M; Fujishiro M; Masuyama H; Nakata R; Abe H; Kumagai S; Fukushima Y; Okubo Y; Hojo S; Kusano M
    J Gastroenterol; 2018 Jul; 53(7):834-844. PubMed ID: 29188387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the effect of ilaprazole on intragastric pH in patients with duodenal ulcer].
    Zhou LY; Lin SR; Yang YS; Zhang ST; Yuan YZ; Shi RH; Hou XH; Xia JL; Hu HT; Qin XH
    Zhonghua Nei Ke Za Zhi; 2010 Apr; 49(4):290-2. PubMed ID: 20627032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of ilaprazole in the treatment of duodenal ulcers: a meta-analysis.
    Ji XQ; Du JF; Chen G; Chen G; Yu B
    World J Gastroenterol; 2014 May; 20(17):5119-23. PubMed ID: 24803828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, safety and pharmacokinetics of ilaprazole infusion in healthy subjects and patients with esomeprazole as positive control.
    Wang H; Shao F; Liu X; Xu W; Ou N; Qin X; Liu F; Hou X; Hu H; Jiang J
    Br J Clin Pharmacol; 2019 Nov; 85(11):2547-2558. PubMed ID: 31332820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized, Double-blind, Active-Controlled, Multi-center Study of Ilaprazole in the Treatment of Reflux Esophagitis.
    Xue Y; Qin X; Zhou L; Lin S; Wang L; Hu H; Xia J
    Clin Drug Investig; 2016 Dec; 36(12):985-992. PubMed ID: 27605258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rabeprazole in treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). The Rabeprazole Study Group.
    Cloud ML; Enas N; Humphries TJ; Bassion S
    Dig Dis Sci; 1998 May; 43(5):993-1000. PubMed ID: 9590413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics, pharmacodynamics and safety of oral doses of ilaprazole 10, 20 and 40 mg and esomeprazole 40 mg in healthy subjects: a randomised, open-label crossover study.
    Shin JS; Lee JY; Cho KH; Park HL; Kukulka M; Wu JT; Kim DY; Park SH
    Aliment Pharmacol Ther; 2014 Sep; 40(5):548-61. PubMed ID: 25041486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The eradicating Helicobacter pylori infection in duodenal ulcer patients by three short-term triple therapies in China: a multicenter clinical comparative study.
    Dai WQ; Zhou YQ; Xu L; Wang BF; Fan XM; Wu JY; Wang CY; Xu XF; Guo CY
    Hepatogastroenterology; 2012; 59(113):296-9. PubMed ID: 22260837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect and safety of anaprazole in the treatment of duodenal ulcers: a randomized, rabeprazole-controlled, phase III non-inferiority study.
    Zhu H; Pan X; Zhang L; Sun H; Fan H; Pan Z; Huang C; Shi Z; Ding J; Wang Q; Du Y; Lyu N; Li Z
    Chin Med J (Engl); 2022 Dec; 135(24):2941-2949. PubMed ID: 36580650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten mg dexrabeprazole daily is as effective as 20 mg rabeprazole daily.
    Kanakia R; Jain S
    World J Gastroenterol; 2008 Jul; 14(28):4586-7. PubMed ID: 18680246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of short-term proton pump inhibitor plus anti-ulcer drug on the healing of endoscopic submucosal dissection-derived artificial ulcer: a randomized controlled trial.
    Nakamura M; Tahara T; Shiroeda H; Matsunaga K; Otsuka T; Yonemura J; Shibata T; Arisawa T
    Hepatogastroenterology; 2015; 62(137):219-24. PubMed ID: 25911899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of efficacy, safety and tolerability rabeprazole in treatment of acid-peptic diseases ].
    de Freitas JA; Lima LM; Ranieri JL; Olivieri JC; Fragoso HJ; Chinzon D
    Arq Gastroenterol; 2002; 39(1):60-5. PubMed ID: 12184168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.